SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The cost‐effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden
10 references·6 citing·36 second hop
The cost‐effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden (2010)The cost‐effectiveness of introducing nuc…Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage: the Bloodhound prospective audit of red blood cell use (2009)Assessment of the urgency and…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Cost‐effectiveness of nucleic…The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)The cost‐effectiveness of NAT…Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001 (2003)Estimation of the risk of hep…Swedish population health-related quality of life results using the EQ-5D (2001)Swedish population health-rel…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Feasibility and efficacy of r…Modeling Valuations for EuroQol Health States (1997)Modeling Valuations for EuroQ…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…EuroQol: the current state of play (1996)EuroQol: the current state of…IMPACT OF MULTIPLEX PCR IN REDUCING THE RISK OF RESIDUAL TRANSFUSION-TRANSMITTED HUMAN IMMUNODEFICIENCY AND HEPATITIS B AND C VIRUSES IN BURKINA FASO (2018)IMPACT OF MULTIPLEX PCR IN RE…NAT positivity in seronegative voluntary blood donors from western India (2016)NAT positivity in seronegativ…Cost effectiveness of adding nucleic acid testing to hepatitis B , hepatitis C , and human immunodeficiency virus screening of blood donations in Z imbabwe (2016)Cost effectiveness of adding …Blood donor deferral: time for change? An evidence-based analysis (2016)Blood donor deferral: time fo…Transfusion sanguine : en toute sécurité d’approvisionnement (2015)Transfusion sanguine : en tou…Myths: history, blood, sex and money. (2013)Myths: history, blood, sex an…EuroQol - a new facility for the measurement of health-related quality of life (1990)Self-Reported Health Status of the General Adult U.S. Population as Assessed by the EQ-5D and Health Utilities Index (2005)The Impact of 29 Chronic Conditions on Health-related Quality of Life: A General Population Survey in Finland Using 15D and EQ-5D (2006)A review of health utilities using the EQ-5D in studies of cardiovascular disease (2010)Effect of a National Disaster on Blood Supply and Safety (2003)Viral attacks on the blood supply: the impact of severe acute respiratory syndrome in Beijing (2004)Boom or bust? Estimating blood demand and supply as the baby boomers age (2011)Profiling clinical platelet and plasma use to inform blood supply and contingency planning: PUPPY, the prospective utilization of platelets and plasma study (2016)Blood management during the COVID-19 pandemic (2020)Recommendations for Reporting Cost-effectiveness Analyses (1996)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States (2004)Estimating the cost of blood: past, present, and future directions (2007)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007 (2009)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Transfusion-transmitted infections (2007)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevention of transfusion-transmitted infections (2019)Methods for the economic evaluation of health care programmes (1987)Perception of Risk (1987)Cost-Effectiveness in Health and Medicine (1996)Lessons from Cost-Effectiveness Research for United States Public Health Policy (2007)Cost-Effectiveness Analysis: What It Really Means for Transfusion Medicine Decision Making (2008)The estimation of a preference-based measure of health from the SF-36 (2002)Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets (2012)Valuing health-related quality of life: An EQ-5D-5L value set for England (2017)EQ-SD: a measure of health status from the EuroQol Group (2001)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) (2011)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Reducing the risk of infection from plasma products: specific preventative strategies (2000)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)
this work references cited by second hop

References

  • 1996EuroQol: the current state of play5,812 cited
  • 1997Modeling Valuations for EuroQol Health States4,543 cited
  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2001Swedish population health-related quality of life results using the EQ-5D664 cited
  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 2003The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations264 cited
  • 1999Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting254 cited
  • 2004Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States136 cited
  • 2003Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001126 cited
  • 2009Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage: the Bloodhound prospective audit of red blood cell use52 cited

Cited by

  • 2018IMPACT OF MULTIPLEX PCR IN REDUCING THE RISK OF RESIDUAL TRANSFUSION-TRANSMITTED HUMAN IMMUNODEFICIENCY AND HEPATITIS B AND C VIRUSES IN BURKINA FASO17 cited
  • 2016Cost effectiveness of adding nucleic acid testing to hepatitis B , hepatitis C , and human immunodeficiency virus screening of blood donations in Z imbabwe

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

14 cited
  • 2016Blood donor deferral: time for change? An evidence-based analysis12 cited
  • 2016NAT positivity in seronegative voluntary blood donors from western India11 cited
  • 2013Myths: history, blood, sex and money.10 cited
  • 2015Transfusion sanguine : en toute sécurité d’approvisionnement8 cited